Inovio Pharmaceuticals, Inc.
CANCER VACCINES TARGETING LEMD1 AND USES THEREOF

Last updated:

Abstract:

Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode a mutated consensus LEMD1 antigen. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode a mutated consensus LEMD1 antigen are disclosed. Methods of treating a subject with a LEMD1-expressing tumor and methods of preventing a LEMD1-expressing tumor are disclosed. Mutated consensus LEMD1 antigen is disclosed.

Status:
Application
Type:

Utility

Filling date:

25 Apr 2022

Issue date:

25 Aug 2022